Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,626-1,650 of 2,022
CompletedNCT05053451

Brain Stimulation, Clinical Symptoms and Cognition

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, Davis
Condition
Schizophrenia
CompletedNCT04968275

A Cannabis Harm Reduction e-Intervention for Young Cannabis Users With Early Psychosis

This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can work better when mental health difficulties overlap with substance use.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
Canada
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Condition
Schizophrenia
CompletedNCT06408740

Physical Activity Level in Psychosis Patients

This study exists to explore whether questionnaires and follow-up reports could improve care and understanding. Researchers are trying to understand whether questionnaires and follow-up reports can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 20 Years to 60 Years
Countries
Turkey
Sponsor
Bandırma Onyedi Eylül University
Condition
Schizophrenia
CompletedNCT04366401

Efficacy of Prebiotic and Probiotic Dietary Modulation in Schizophrenic Disorders

This study exists to understand what helps a therapy or guided support program work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Spain
Sponsor
Universidad de Córdoba
Condition
Schizophrenia
TerminatedNCT01908192

Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®

This study exists to explore whether symptom tracking and monitoring could improve care and understanding. Researchers are trying to understand whether symptom tracking and monitoring can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 12 Years to 17 Years
Countries
Taiwan, United States
Sponsor
SyneuRx International (Taiwan) Corp
Condition
Schizophrenia
RecruitingNCT04452175

Cigarette Consumption After switchinG to High or Low Nicotine strENght E-cigaretteS In Smokers With Schizophrenia

This study exists to see whether smoking support or smoking-related treatment is workable and worth testing more broadly. Researchers are trying to understand whether smoking support or smoking-related treatment can better prevent setbacks and support longer-term stability.

SchizophreniaOtherOver 18 Years
Countries
Italy
Sponsor
University of Catania
Condition
Schizophrenia
RecruitingNCT05252039

Goals in Focus: CBT for Motivational Negative Symptoms of Psychosis

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 16 Years to 85 Years
Countries
Germany
Sponsor
University of Hamburg-Eppendorf
Condition
Schizophrenia
CompletedNCT03323437

Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United States
Sponsor
Weill Medical College of Cornell University
Condition
Schizophrenia
RecruitingNCT05445180

Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use

This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 16 Years to 80 Years
Countries
Canada
Sponsor
Douglas Mental Health University Institute
Condition
Schizophrenia
CompletedNCT02129348

Treatment of Psychosis and Agitation in Alzheimer's Disease

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOther
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
CompletedNCT02775864

Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia

This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand whether a therapy or guided support program can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
Global
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
CompletedNCT04248517

Using mHealth to Optimize Pharmacotherapy Regimens

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 16 Years to 30 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
RecruitingNCT05823532

Anti-Inflammatory Challenge in Schizophrenia

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
Emory University
Condition
Schizophrenia
CompletedNCT03822910

Hippocampal Memory Circuits in Delusions

This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 16 Years to 35 Years
Countries
China, United States
Sponsor
NYU Langone Health
Condition
Schizophrenia
CompletedNCT01425671

Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 14 Years to 62 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
CompletedNCT01892384

Safety and Tolerability of BI 409306 in Patients With Schizophrenia

This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
CompletedNCT05739344

The Effect of Developing Psychological Resilience on Functionality in Schizophrenia Patients

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Turkey
Sponsor
Sisli Hamidiye Etfal Training and Research Hospital
Condition
Schizophrenia
TerminatedNCT05319080

Individualized Repetitive Transcranial Magnetic Stimulation for Auditory Verbal Hallucinations

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 22 Years to 55 Years
Countries
United States
Sponsor
Columbia University
Condition
Schizophrenia
RecruitingNCT05329363

Evaluation of the Individual Early Psychoeducation Program for Schizophrenic Disorders in Inpatients

This study exists to explore whether psychoeducation, a guided learning and support program, could improve care and understanding. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
University Hospital, Tours
Condition
Schizophrenia
CompletedNCT01573637

Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women

This study exists to compare options and see whether acceptance and commitment therapy, a talking treatment, offers something meaningfully different. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 45 Years
Countries
Spain
Sponsor
Fundació Sant Joan de Déu
Condition
Schizophrenia
CompletedNCT02392468

Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers

This study exists to better understand the safety of the medication Systemic and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication Systemic in practice and what may need to be adjusted.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia